Single-cell analysis of patient samples revealed that EREG is primarily expressed by TAMs in the NSCLC TME and treatment with macrophage-conditioned media conferred resistance to small molecule EGFR inhibitor gefitinib in NSCLC cells. The gene discussed is EREG; the disease is non-small cell lung carcinoma.